Literature DB >> 8171277

The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study.

L Agréus1, K Svärdsudd, O Nyrén, G Tibblin.   

Abstract

The prevalence of abdominal symptoms was studied by means of a postal questionnaire sent to a representative sample (n = 1290) of the adult population of a Swedish municipality. The subjects were asked about the occurrence of 35 abdominal symptoms during the preceding 3 months. The participation rate was 89.6%, and 54.3% of the responders reported at least one discomforting abdominal symptom. The overall prevalence rate was significantly higher in women than in men, and the highest rate (75%) was found among young women. The average number of symptoms per individual was also significantly higher in women. The overall prevalence rate in women decreased significantly with age, irrespective of menopause. The prevalence of most individual symptoms decreased with age and/or was higher in women. However, the prevalence of symptoms indicative of gastro-oesophageal reflux disease did not vary with age or sex. The prevalence of symptoms usually regarded as ominous did not increase with age; in some instances it even decreased. With the exception of reflux symptoms and night pain, the apparent disappearance with increasing age implies that most of the complaints are of functional origin.

Entities:  

Mesh:

Year:  1994        PMID: 8171277     DOI: 10.3109/00365529409090447

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  30 in total

Review 1.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Consensus guidelines for evaluating and treating patients with upper gastrointestinal symptoms in the primary care setting.

Authors:  M J Whitaker
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

3.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Prevalence of symptomatic pelvic organ prolapse in a Swedish population.

Authors:  Gunilla Tegerstedt; Marianne Maehle-Schmidt; Olof Nyrén; Margareta Hammarström
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-06-29

5.  Gastrointestinal symptoms in a Japanese population: a health diary study.

Authors:  Yasuharu Tokuda; Osamu Takahashi; Sachiko Ohde; Masaaki Shakudo; Haruo Yanai; Takuro Shimbo; Shunichi Fukuhara; Shigeaki Hinohara; Tsuguya Fukui
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 6.  Gastrointestinal surgery in old age: issues of equality and quality.

Authors:  D G Seymour
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

7.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.

Authors:  Aldona Dlugosz; Hans Törnblom; Ghazaleh Mohammadian; Gareth Morgan; Béla Veress; Benjamin Edvinsson; Gunnar Sandström; Greger Lindberg
Journal:  BMC Gastroenterol       Date:  2010-02-16       Impact factor: 3.067

9.  Long-term prognosis after operation for adhesive small bowel obstruction.

Authors:  Bjørg-Tilde Svanes Fevang; Jonas Fevang; Stein Atle Lie; Odd Søreide; Knut Svanes; Asgaut Viste
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus.

Authors:  Jung-Hwan Oh; Myung-Gyu Choi; Moo-Il Kang; Kang-Moon Lee; Jin Il Kim; Byung-Wook Kim; Dong-Soo Lee; Sung-Soo Kim; Hwang Choi; Sok-Won Han; Kyu-Yong Choi; Ho-Young Son; In-Sik Chung
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.